Update and Developments in the Treatment of Glioblastoma Multiforme &Ndash; Focus on Bevacizumab

Pharmacogenomics and Personalized Medicine - New Zealand
doi 10.2147/pgpm.s7940
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Identification of Targets and New Developments in the Treatment of Multiple Sclerosis &Ndash; Focus on Cladribine

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2010English

Dendritic Cell Vaccination for Glioblastoma Multiforme: Review With Focus on Predictive Factors for Treatment Response

ImmunoTargets and Therapy
AllergyImmunology
2014English

A Budget Impact Model for the Introduction of Bevacizumab for the Treatment of Newly Diagnosed Glioblastoma Multiforme in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

New Developments in the Treatment of Basal Cell Carcinoma: Update on Current and Emerging Treatment Options With a Focus on Vismodegib

OncoTargets and Therapy
OncologyPharmacology
2018English

Complete Response With Fotemustine and Bevacizumab After Early Progression Following Radiotherapy and Temozolomide Treatment in Patient With Glioblastoma Multiforme

Journal of Cancer Metastasis and Treatment
2015English

Efficacy and Safety of Bevacizumab for the Treatment of Glioblastoma

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2015English

New Developments in the Management of Opioid Dependence: Focus on Sublingual Buprenorphine–naloxone

Substance Abuse and Rehabilitation
2015English

Glioblastoma Multiforme: A Review of Its Pathogenesis and Treatment

International Research Journal Of Pharmacy
2019English

The Emerging Role of Stereotactic Radiosurgery in the Treatment of Glioblastoma Multiforme

Current Radiopharmaceuticals
Nuclear MedicineRadiologyImagingPharmacology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy